UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 373

Sortiert nach

A WHO key informant language survey of people with lived experiences of diabetes: Media misconceptions, values-based messaging, stigma, framings and communications considerations

Diabetes research and clinical practice, 2022-11, Vol.193, p.110109-110109, Article 110109

2022

Volltextzugriff (PDF)

AI-Based Adherence Prediction for Patients: Leveraging a Mobile Application to Improve Clinical Trials

CNS spectrums, 2023-04, Vol.28 (2), p.224-224

2023

Volltextzugriff (PDF)

S190. Prevention of Relapse in Schizophrenia: A Phase II Study Evaluating Efficacy, Safety, and Tolerability of Oral BI 409306

Biological psychiatry (1969), 2018-05, Vol.83 (9), p.S421-S421

2018

Volltextzugriff (PDF)

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Schizophrenia bulletin, 2019-03, Vol.45 (2), p.350-359

2019

Volltextzugriff (PDF)

Observations by Caregivers Using the Infant with Clefts Observation Outcomes Instrument (iCOO): A Comparison of Three Versus Seven-day Daily Diaries

The Cleft palate-craniofacial journal, 2024-09, Vol.61 (9), p.1538-1542

2024

Volltextzugriff (PDF)

T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Biological psychiatry (1969), 2018-05, Vol.83 (9), p.S207-S208

2018

Volltextzugriff (PDF)

A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia

Neurology and therapy, 2018-06, Vol.7 (1), p.129-139

2018

Volltextzugriff (PDF)

Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes: A 6-month, Randomized, Double-blind, Placebo-controlled Study

Endocrine practice, 2014-05, Vol.20 (5), p.412-420

2014

Volltextzugriff (PDF)

21. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study

Schizophrenia bulletin, 2017-03, Vol.43 (suppl_1), p.S15-S15

2017

Volltextzugriff (PDF)

A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale

Early intervention in psychiatry, 2021-10, Vol.15 (5), p.1315-1325

2021

Volltextzugriff (PDF)

Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin

Expert opinion on pharmacotherapy, 2012-12, Vol.13 (17), p.2443-2452

2012

Volltextzugriff (PDF)

Created Equal

National Catholic Reporter, 2018-02, Vol.54 (10), p.13-15

Daniels, Kristen Whitney

2018

Volltextzugriff (PDF)

Death penalty in 2017

National Catholic Reporter, 2018-01, Vol.54 (7), p.1A-3A

Daniels, Kristen Whitney

2018

Volltextzugriff (PDF)

Ohio scrutinizes execution drug

National Catholic Reporter, 2017-05, Vol.53 (15), p.7

Daniels, Kristen Whitney

2017

Volltextzugriff (PDF)

States debate death penalty issues

National Catholic Reporter, 2017-03, Vol.53 (12), p.13

Daniels, Kristen Whitney

2017

Volltextzugriff (PDF)

EDUCATING STUDENTS IN SHAKESPEARE

National Catholic Reporter, 2017-02, Vol.53 (10), p.1A

Daniels, Kristen Whitney

2017

Volltextzugriff (PDF)

An expedition into college life

National Catholic Reporter, 2016-11, Vol.53 (2), p.3A

Daniels, Kristen Whitney

2016

Volltextzugriff (PDF)

Supporting the church's outposts

National Catholic Reporter, 2016-09, Vol.52 (25), p.1A

Daniels, Kristen Whitney

2016

Volltextzugriff (PDF)

A true pilgrimage

National Catholic Reporter, 2016-08, Vol.52 (22), p.5

Daniels, Kristen Whitney

2016

Volltextzugriff (PDF)

Rock for a Cause

Daily herald (Arlington Heights, Ill. : Arlington Heights ed.), 2017-02-25, p.0

Daniels, Kristen

2017

Volltextzugriff (PDF)

Clearbrook on Cue Performs to Full House of Fans

Daily herald (Arlington Heights, Ill. : Arlington Heights ed.), 2016-06-30, p.0

Daniels, Kristen

2016

Volltextzugriff (PDF)

Death penalty teaching revised

National Catholic Reporter, 2018-08, Vol.54 (23), p.1-10

Daniels, Kristen Whitney

2018

Volltextzugriff (PDF)

'Created Equal': Film uses women's ordination to address broader societal issues

National Catholic reporter, 2018-02, Vol.54 (10), p.13

Daniels, Kristen Whitney

2018

Volltextzugriff (PDF)

Though activists saw abolition referendum defeats, they point to trends that show capital punishment in 'free fall': Death penalty in 2017

National Catholic reporter, 2018-01, Vol.54 (7), p.1

Daniels, Kristen Whitney

2018

Volltextzugriff (PDF)

Helen Prejean sways hearts with stories.(MINISTRY & MISSION)

National Catholic Reporter, 2017-09, Vol.53 (24), p.1

Daniels, Kristen Whitney

2017

Volltextzugriff (PDF)

1 – 25 von 373

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(318)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(373)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A WHO key informant language survey of people with lived experiences of diabetes: Media misconceptions, values-based messaging, stigma, framings and communications considerations

AI-Based Adherence Prediction for Patients: Leveraging a Mobile Application to Improve Clinical Trials

S190. Prevention of Relapse in Schizophrenia: A Phase II Study Evaluating Efficacy, Safety, and Tolerability of Oral BI 409306

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Observations by Caregivers Using the Infant with Clefts Observation Outcomes Instrument (iCOO): A Comparison of Three Versus Seven-day Daily Diaries

T205. Effect of BI 409306 on Positive and Negative Syndrome Scale in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia

Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes: A 6-month, Randomized, Double-blind, Placebo-controlled Study

21. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study

A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale

Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin

Created Equal

Death penalty in 2017

Ohio scrutinizes execution drug

States debate death penalty issues

EDUCATING STUDENTS IN SHAKESPEARE

An expedition into college life

Supporting the church's outposts

A true pilgrimage

Rock for a Cause

Clearbrook on Cue Performs to Full House of Fans

Death penalty teaching revised

'Created Equal': Film uses women's ordination to address broader societal issues

Though activists saw abolition referendum defeats, they point to trends that show capital punishment in 'free fall': Death penalty in 2017

Helen Prejean sways hearts with stories.(MINISTRY & MISSION)

Suchergebnisse filtern